Greg Meyers, Bristol Myers Squibb chief digital and technology officer
September 23, 2024 10:00 AM EDT
People
R&D
AI

Q&A: Bris­tol My­ers’ tech chief on the promis­es and per­ils of AI bio

Andrew Dunn

Senior Biopharma Correspondent

For AI-fo­cused star­tups seek­ing out phar­ma deals, they have to go through peo­ple like Greg Mey­ers, the chief dig­i­tal and tech­nol­o­gy of­fi­cer at Bris­tol My­ers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times